Answers are grounded in this paper and cite their sources.
Positron emission tomography (PET) imaging of neurodegenerative disease has historically focused on a small number of established targets. The development of selective PET radiotracers for novel biological targets enables new ways to interrogate the neuropathology of proteinopathies and will advance our understanding of neurodegeneration. This perspective aims to highlight recent PET radiotracers developed for five emerging targets in proteinopathies (i.e., mHTT, BACE1, TDP-43, OGA, and CH24H).
No takes yet. Share an insight, caveat, or question.
Chassé et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: